Press Releases Items Per Page 102550 Year None202320222021202020192018201720162015201420132012201120102007 09.09.10 Syndax Pharmaceuticals to Present at R.W. Baird 2010 Healthcare Conference and BioPharm America 2010 08.11.10 Syndax Pharmaceuticals raises $6 Million in Securities Offering 06.04.10 Syndax Pharmaceuticals' Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer 05.24.10 Syndax Pharmaceuticals Inc. to Present Entinostat Data Showing Benefit in Combination in Advanced Breast Cancer at ASCO 06.06.07 FierceBiotech Names Syndax Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2007 04.13.07 Syndax Pharmaceuticals Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275 04.03.07 Syndax Pharmaceuticals Inc. closes $40 Million Series A Financing Pagination First page « first Previous page ‹ previous … Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Current page 22
09.09.10 Syndax Pharmaceuticals to Present at R.W. Baird 2010 Healthcare Conference and BioPharm America 2010
06.04.10 Syndax Pharmaceuticals' Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
05.24.10 Syndax Pharmaceuticals Inc. to Present Entinostat Data Showing Benefit in Combination in Advanced Breast Cancer at ASCO
06.06.07 FierceBiotech Names Syndax Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2007
